1.Hemorrhagic Cystitis due to Intravesical Instillation of Gentian Violet Completely Recovered with Conservative Therapy.
Se Joong KIM ; Dong Hee KOH ; Jung Seun PARK ; Hyun Soo AHN ; Jong Bo CHOI ; Young Soo KIM
Yonsei Medical Journal 2003;44(1):163-165
Chemical cystitis due to intravesical instillation of gentian violet or crystal violet is rare and all of the reported cases have been in adults using undiluted solution, which resulted in long-term sequelae. This is a case report on a 16-month-old boy with hemorrhagic cystitis after the instillation of diluted gentian violet into the bladder to rule out bladder injury during inguinal herniorrhaphy. Although he was completely recovered with conservative therapy, gentian violet, even when diluted, should not be used on the urinary tract.
Administration, Intravesical
;
Bladder Diseases/*chemically induced/*therapy
;
Cystitis/*chemically induced/*therapy
;
Gentian Violet/*administration & dosage/*adverse effects
;
Hemorrhage/*chemically induced/*therapy
;
Human
;
Infant
;
Male
3.Adverse events related to bevacizumab and the management principles in non-small cell lung cancer.
Chinese Journal of Lung Cancer 2010;13(6):563-567
Angiogenesis Inhibitors
;
adverse effects
;
Antibodies, Monoclonal
;
adverse effects
;
Antibodies, Monoclonal, Humanized
;
Bevacizumab
;
Carcinoma, Non-Small-Cell Lung
;
drug therapy
;
Hemorrhage
;
chemically induced
;
Humans
;
Hypertension
;
chemically induced
;
Lung Neoplasms
;
drug therapy
;
Proteinuria
;
chemically induced
;
Thromboembolism
;
chemically induced
4.Penicillin G-induced hemorrhagic cystitis.
The Korean Journal of Internal Medicine 2015;30(5):742-742
5.Risk analysis for aspirin and postoperative intracranial hemorrhage--report of 3 cases.
Shu-qing YU ; Ji-sheng WANG ; Nan JI ; Wei LIU ; Ke QIAN
Chinese Medical Journal 2009;122(10):1231-1233
6.Generation mechanisms and management strategies of adverse reactions to Bevacizumab during cancer treatment.
Chinese Journal of Oncology 2010;32(7):481-486
Angiogenesis Inhibitors
;
adverse effects
;
therapeutic use
;
Angiotensin-Converting Enzyme Inhibitors
;
therapeutic use
;
Antibodies, Monoclonal
;
adverse effects
;
therapeutic use
;
Antibodies, Monoclonal, Humanized
;
Aspirin
;
administration & dosage
;
therapeutic use
;
Bevacizumab
;
Hemorrhage
;
chemically induced
;
Humans
;
Hypertension
;
chemically induced
;
drug therapy
;
Intestinal Perforation
;
chemically induced
;
surgery
;
Neoplasms
;
drug therapy
;
Proteinuria
;
chemically induced
;
Thromboembolism
;
chemically induced
;
drug therapy
7.The Effect of Non-steroidal Anti-inflammatory Drugs in Upper Gastrointestinal Bleeding.
Sang Woo LEE ; Hak Yang KIM ; Soo Heon PARK ; Ki Baik HAHM ; Jong Myon BAE ; Hyun Chae JUNG ; Jin Ho KIM
The Korean Journal of Gastroenterology 2004;44(1):13-18
BACKGROUND/AIMS: To evaluate the association between non-steroidal anti-inflammatory drugs (NSAIDs) use and upper gastrointestinal (UGI) bleeding, we performed a case-control study at the six University affiliated hospitals for one year. METHODS: Case and control subjects matched for age and sex were selected by endoscopy. Subjects were asked for the use of NSAIDs, past medical history, history of other medications, and smoking. The age and sex adjusted risk for UGI bleeding with NSAIDs use was compared between the case and control groups. RESULTS: The odd ratios of UGI bleeding with NSAIDs intake adjusted for past medical and medication history, past medical history only, and medication history only were 5.0, 5.0, and 1.7, respectively. The cases had significantly more history of NSAIDs intake, more diseases in medical history, and more medications other than NSAIDs compared to the controls. There was no relationship between UGI bleeding and concomitant medications in the both groups. CONCLUSIONS: This multicenter study suggests that a history of NSAIDs intake is strongly associated with UGI bleeding in Korea.
Anti-Inflammatory Agents, Non-Steroidal/*adverse effects
;
Case-Control Studies
;
English Abstract
;
Gastrointestinal Hemorrhage/*chemically induced
;
Humans
9.A case of bromadiolone poisoning leading to digestive tract, abdominal hemorrhage and secondary paralytic ileus.
Hong Fan CHEN ; Zhi Jian ZHANG ; Cheng Jin YOU ; Li CHEN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2022;40(9):707-709
Bromadiolone, commonly known as super warfarin, is a long-acting coumarin dicoumarin rodenticide. The mechanism of bromadiolone is mainly to inhibit vitamin K1 epoxide reductase and affect the synthesis of coagulation factors Ⅱ, Ⅶ, Ⅸ and Ⅹ, which causes blood coagulation dysfunction and systemic multiple organ hemorrhage. Here, we report of a case of bromadiolone poisoning patient who had digestive tract, abdominal hemorrhage, as well as secondary paralytic ileus. After blood product transfusion and vitamin K1 supplementation, the patient was discharged after the physical condition was improved. It's suggestied that clinicians should pay attention to rare complications to prevent missed diagnosis when treating other bromadiolone poisoning.
4-Hydroxycoumarins
;
Blood Coagulation Factors
;
Dicumarol
;
Hemorrhage
;
Humans
;
Intestinal Pseudo-Obstruction/chemically induced*
;
Oxidoreductases
;
Rodenticides
;
Vitamin K 1
;
Warfarin
10.Interaction between Warfarin and the Herbal Product Shengmai-Yin: A Case Report of Intracerebral Hematoma.
Yonsei Medical Journal 2010;51(5):793-796
A 71-year-old man was stable on warfarin (2.25 mg daily) therapy with an international normalized ratio (INR) of 1.8-2.2 after a heart valve replacement surgery. Recently, he consumed the liquid-like herbal product called shengmai-yin (10 mL daily) against medical advice. Seven days after the daily consumption of shengmai-yin, he was admitted to the intensive care unit because of consciousness disturbance [Glasgow Coma Scale (GCS) score 7] with an INR of 5.08. Head computed topography revealed intracerebral hematoma in the left temporoparietal region. Both warfarin therapy and the herbal product were withdrawn. At the same time, therapy with intravenous vitamin K1 40 mg was started. On the second day of admission, craniectomy was performed to remove the intacerebral hematoma under general anesthesia. He remained confused and restless for 2 days, but then showed progressive recovery in the consciousness level as well as motor and verbal functions. Shengmai-yin contains herbal ingredients that can interact with warfarin. The Drug Interaction Probability Scale (DIPS) indicated that warfarin and shengmai-yin were highly probable causes of intracerebral hematoma. Patients on warfarin therapy should be discouraged from taking herbal medicines, especially preparations that are already known to have antiplatelet and antithrombotic effects.
Aged
;
Anticoagulants/*adverse effects/therapeutic use
;
Cerebral Hemorrhage/*chemically induced/drug therapy/surgery
;
Drug Interactions
;
Drugs, Chinese Herbal/*adverse effects
;
Hematoma/*chemically induced/drug therapy/surgery
;
Humans
;
Male
;
Treatment Outcome
;
Vitamin K 1/therapeutic use
;
Warfarin/*adverse effects/*therapeutic use